Company news
Acrux Limited news in 2021
Acrux Limited's news releases, calls and decks from 2021, newest first.
Acrux and Harris terminate license agreement
October 10, 2021
Acruxs fifth generic dossier accepted by FDA for review
September 12, 2021
Acrux Investor Presentation - September 2021
September 1, 2021
US Launch - Testosterone Topical Solution
August 25, 2021
Appendix 4E and Financial Report
August 25, 2021
Acrux receives third FDA ANDA approval
July 27, 2021
Acrux Receives FDA Approval - Generic Efinaconazole Solution
June 22, 2021
Acrux confirms patent challenge
June 7, 2021
Acruxs fourth generic dossier accepted by FDA for review
April 15, 2021
Acrux Investor Presentation
February 24, 2021
Appendix 4D and Half Year Accounts - for the 31 Dec ac
February 24, 2021
Share Purchase Plan Closes Oversubscribed
February 2, 2021
Acrux Receives FDA Approval - Generic Testosterone Solution
January 11, 2021
Acrux Ltd Share Purchase Plan Offer Booklet
January 7, 2021
Decks in 2021
- Investor Presentation (September 2021)
Investor deck · 13 slides · Sep 2, 2021
- Investor Presentation (February 2021)
Investor deck · 13 slides · Feb 25, 2021